GLPwatch
Papers (12034)
Page 82 of 201, ranked by citation count.
- A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
- Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.
- Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects.
- Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential.
- Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.
- Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study.
- Role of GLP1-RA in Optimizing Weight Loss Post-Bariatric Surgery: A Systematic Review and Meta-Analysis.
- Exendin-4 antagonizes the metabolic action of acylated ghrelinergic signaling in the hypothalamic paraventricular nucleus.
- Liraglutide administration improves hormonal/metabolic profile and reproductive features in women with HAIR-AN syndrome.
- Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients.
- Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: a network meta-analysis.
- Liraglutide pharmacokinetics and exposure-response in adolescents with obesity.
- Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
- Liraglutide Treatment Ameliorates Neurotoxicity Induced by Stable Silencing of Pin1.
- Exenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice.
- Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands.
- Effect of the glucagon-like peptide-1 receptor agonists on diabetic peripheral neuropathy: A meta-analysis.
- Long-Term Efficacy and Safety of Nutritional and Pharmacological Strategies for Obesity.
- Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.
- Semaglutide mitigates testicular damage in diabetes by inhibiting ferroptosis.
- Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach.
- Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY<sub>3-36</sub> Combination Therapy in Diet-Induced Obese Rats.
- GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report.
- Exendin-4 protects murine pancreatic β-cells from dexamethasone-induced apoptosis through PKA and PI-3K signaling.
- The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes.
- Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats.
- Magnetically-driven implantable pump for on-demand bolus infusion of short-acting glucagon-like peptide-1 receptor agonist.
- A GLP1R gene variant and sex influence the response to semaglutide treatment in patients with severe obesity.
- Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice.
- Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.
- Semaglutide outperforms insulin in restoring neutrophil function against implant-related infection in diabetic and obese mice: experimental research.
- The efficacy and safety of liraglutide.
- Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment.
- Liraglutide Improves PCOS Symptoms in Rats by Targeting FDX1.
- Exenatide Prevents Morphological and Structural Changes of Mitochondria Following Ischaemia-Reperfusion Injury.
- Exenatide Regulates Substrate Preferences Through the p38γ MAPK Pathway After Ischaemia/Reperfusion Injury in a Rat Heart.
- Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus.
- Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats.
- Semaglutide-eye-catching results.
- Dietary Calanus oil recovers metabolic flexibility and rescues postischemic cardiac function in obese female mice.
- Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats.
- Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats.
- Effectiveness and tolerability of liraglutide for the management of weight regain following sleeve gastrectomy.
- The glucagon-like peptide-1 receptor agonist Exendin-4, ameliorates contrast-induced nephropathy through suppression of oxidative stress, vascular dysfunction and apoptosis independent of glycaemia.
- Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment.
- Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes.
- Liraglutide in oral antidiabetic drug combination therapy.
- More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L.
- Exenatide induces autophagy and prevents the cell regrowth in HepG2 cells.
- Corrigendum: Safety of Semaglutide.
- A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin based therapy.
- Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy.
- Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/β-catenin signaling pathway.
- Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
- GLP-1 preserves β cell function via improvement on islet insulin signaling in high fat diet feeding mice.
- EFFICACY AND SAFETY OF DULAGLUTIDE IN HISPANIC/LATINO PATIENTS WITH TYPE 2 DIABETES IN THE AWARD CLINICAL PROGRAM.
- The effects of a GLP-1 analog liraglutide on reward value and the learned inhibition of appetitive behavior in male and female rats.
- A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
- Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model.
- Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus.